Immediate Impact

66 standout
Sub-graph 1 of 21

Citing Papers

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Comparison of pharmacological therapies in metabolic dysfunction–associated steatohepatitis for fibrosis regression and MASH resolution: Systematic review and network meta-analysis
2025 Standout
3 intermediate papers

Works of Stephanie Rutledge being referenced

Prolonged cenicriviroc therapy reduces hepatic fibrosis despite steatohepatitis in a diet‐induced mouse model of nonalcoholic steatohepatitis
2018

Author Peers

Author Last Decade Papers Cites
Stephanie Rutledge 287 235 96 21 443
Gianni Testino 258 210 109 36 393
M E Callender 183 195 63 19 382
Paola Mancino 168 131 17 26 469
Hyo Suk Lee 223 209 68 22 397
Junfeng Zhang 241 76 39 25 404
Hong‐Lei Ma 344 146 37 27 437
Annette Dam Fialla 322 252 112 19 457
Emanuele Muraca 241 102 53 23 401
María Pilar Ballester 258 205 38 35 418
Kei Sawara 244 306 43 36 465

All Works

Loading papers...

Rankless by CCL
2026